KIMBERLY KESSLER: Open Payments
NPI 1679262968 · PRINCETON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 51 payments from 10 companies in 2025. Trend: 2023 $658 · 2024 $1,927 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $267 |
| AstraZeneca Pharmaceuticals LP | 6 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $179 |
| Otsuka America Pharmaceutical, Inc. | 6 | $171 |
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| Novo Nordisk Inc | 3 | $67 |
| Travere Therapeutics, Inc. | 4 | $47 |
| Calliditas Therapeutics US Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
Products named: JARDIANCE, FARXIGA, Kerendia, JYNARQUE, Fabhalta, Ozempic, TARPEYO, TERLIVAZ.
Industry payments across WV — which companies pay providers there.
